HOME >> MEDICINE >> NEWS
Joint meeting on Agent Orange set for March 3-6 in Hanoi

In an initial effort at scientific cooperation on studies of the use of chemical defoliants during the Vietnam War, the U.S.-Vietnam Scientific Conference on Human Health and Environmental Effects of Agent Orange/Dioxins will be held March 3 to 6 at the Daewoo Hotel in Hanoi, the United States'organizing group announced today.

The National Institute of Environmental Health Sciences, a part of the federal National Institutes of Health, said the meeting will bring together experts from around the world to discuss what's known about the effects of Agent Orange and its major contaminants - the Dioxins, what's known about reducing the exposures of people to these chemicals, and what further research may be needed. The conference is expected to provide a foundation for cooperative research projects and future research funding.

The agenda for the meeting and other information are available at http://www.niehs.nih.gov/external/usvcrp/home.htm

For registration and accommodations information, scientists should contact Amy Hartlaub at (202) 973-8693 or US-Vietnam@courtesyassoc.com.

The U.S. members of the organizing committee are Christopher Portier and Walter Rogan of the NIEHS; William Farland of the Environmental Protection Agency; Drue Barrett of the Centers for Disease Control and Prevention; Linda Schwartz of the Yale University School of Nursing; Brenda Eskenazi of the University of California at Berkeley, and Sandra Lange (US coordinator) of NIEHS. The Vietnamese members are Le Ngoc Trong, Vice Minister of Health; Nguyen Ngoc Sinh, director general of the National Environment Agency; Nguyen Van Tuong of Hanoi Medicine College; Tran Van Phuong of the Ministry of Health (Vietnamese coordinator); Tran Van Tu, Ministry of Foreign Affairs; Dang Vinh Thien of the Vietnam Association on Conservation of Nature and Environment P
'"/>

Contact: Bill Grigg
grigg@niehs.nih.gov
301-402-3378
NIH/National Institute of Environmental Health Sciences
7-Feb-2002


Page: 1 2

Related medicine news :

1. Joint-custody arrangements good for children of divorce -- but only if there is no parental conflict
2. CDC: Arthritis and Chronic Joint Symptoms
3. A Change In Climate May Mean More Than Creaky Joints: Symposium At ESA Annual Meeting Will Examine Linkages Between Ecological Change And Human Health
4. ENDO 2005 - The Endocrine Societys 87th annual meeting
5. Houston meeting kicks off collaboration to advance cancer research
6. Lectures, keynoters, symposia highlight International Dental Research meeting
7. Society for Research in Child Development (SRCD) biennial meeting
8. NHS Trusts meeting government target on stroke units in name only
9. Medical meeting to feature research findings and disease prevention and health promotion sessions
10. Ethics of neuroimaging research to be focus of NIH/Stanford meeting
11. Academy meeting examines the vaccine & avian influenza crisis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Joint meeting Agent Orange set for March Hanoi

(Date:5/20/2013)... VHA Inc., the national health care ... population health improvement, announced a new offering to ... pursue population health management with a strategic ... the transition to value-based models of care. As ... of services, the offering integrates VHA expert advisory ...
(Date:5/20/2013)... have mapped the significance of heredity for common ... examined whether different forms of the disease share ... ischemic stroke, peripheral arterial disease and atherosclerosis of ... have suffered different types of cardiovascular disease. , ... atherosclerosis of the aorta followed by peripheral arterial ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy ... lawsuits, is troubled by a new study that reveals ... type 2 diabetes drugs are growing. The analysis, ... found that 71 Byetta pancreatic cancer reports had been ... as of June 30, 2012. Overall, Byetta ...
(Date:5/20/2013)... Newport News, VA (PRWEB) May 20, 2013 ... Jeffrey Carlson successfully performed a procedure using SpineFrontier’s FacetFuse ... Fusion Device System. The operation took place on ... Hospital in Newport News, VA. The surgery was ... a 66 year-old, female patient. , Dr. Carlson described ...
(Date:5/20/2013)... The study comprised over 24,000 Finnish subjects and ... revealed that a panel of 28 genetic markers ... coronary heart disease (CHD) (10-year risk ≥20%) over ... is an important preventive strategy for CHD, because ... high-risk group. "The results indicate that genetic markers ...
Breaking Medicine News(10 mins):Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
Cached News: